[go: up one dir, main page]

WO2001055168A8 - Acides nucleiques, proteines, et anticorps - Google Patents

Acides nucleiques, proteines, et anticorps

Info

Publication number
WO2001055168A8
WO2001055168A8 PCT/US2001/001331 US0101331W WO0155168A8 WO 2001055168 A8 WO2001055168 A8 WO 2001055168A8 US 0101331 W US0101331 W US 0101331W WO 0155168 A8 WO0155168 A8 WO 0155168A8
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
antibodies
further relates
present
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/001331
Other languages
English (en)
Other versions
WO2001055168A1 (fr
Inventor
Craig A Rosen
Steven C Barash
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to EP01910333A priority Critical patent/EP1259528A1/fr
Priority to AU2001237951A priority patent/AU2001237951A1/en
Publication of WO2001055168A1 publication Critical patent/WO2001055168A1/fr
Publication of WO2001055168A8 publication Critical patent/WO2001055168A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouvelles protéines et, plus particulièrement, des molécules d'acide nucléique isolées codant de nouveaux polypeptides, ainsi que de nouveaux polypeptides et des anticorps qui se lient à ces polypeptides. L'invention concerne également des vecteurs, des cellules hôtes, et des méthodes recombinantes et synthétiques de production de polynucléotides et/ou de polypeptides humains et des anticorps. Elle concerne des méthodes diagnostiques et thérapeutiques servant à diagnostiquer, traiter, prévenir et/ou pronostiquer des troubles liés à ces nouveaux polypeptides. Elle concerne en outre des méthodes de criblage permettant d'identifier des agonistes et des antagonistes des polynucléotides et polypeptides de l'invention. L'invention concerne enfin des méthodes et des compositions pouvant inhiber ou améliorer la production et la fonction des polypeptides de l'invention.
PCT/US2001/001331 2000-01-31 2001-01-17 Acides nucleiques, proteines, et anticorps Ceased WO2001055168A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01910333A EP1259528A1 (fr) 2000-01-31 2001-01-17 Acides nucleiques, proteines, et anticorps
AU2001237951A AU2001237951A1 (en) 2000-01-31 2001-01-17 Nucleic acids, proteins and antibodies

Applications Claiming Priority (235)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US60/179,065 2000-01-31
US18062800P 2000-02-04 2000-02-04
US60/180,628 2000-02-04
US18466400P 2000-02-24 2000-02-24
US60/184,664 2000-02-24
US18635000P 2000-03-02 2000-03-02
US60/186,350 2000-03-02
US18987400P 2000-03-16 2000-03-16
US60/189,874 2000-03-16
US19007600P 2000-03-17 2000-03-17
US60/190,076 2000-03-17
US19812300P 2000-04-18 2000-04-18
US60/198,123 2000-04-18
US20551500P 2000-05-19 2000-05-19
US60/205,515 2000-05-19
US20946700P 2000-06-07 2000-06-07
US60/209,467 2000-06-07
US21488600P 2000-06-28 2000-06-28
US60/214,886 2000-06-28
US21513500P 2000-06-30 2000-06-30
US60/215,135 2000-06-30
US21664700P 2000-07-07 2000-07-07
US21688000P 2000-07-07 2000-07-07
US60/216,647 2000-07-07
US60/216,880 2000-07-07
US21748700P 2000-07-11 2000-07-11
US21749600P 2000-07-11 2000-07-11
US60/217,487 2000-07-11
US60/217,496 2000-07-11
US21829000P 2000-07-14 2000-07-14
US60/218,290 2000-07-14
US22096400P 2000-07-26 2000-07-26
US22096300P 2000-07-26 2000-07-26
US60/220,964 2000-07-26
US60/220,963 2000-07-26
US22526700P 2000-08-14 2000-08-14
US22575700P 2000-08-14 2000-08-14
US22575800P 2000-08-14 2000-08-14
US22521300P 2000-08-14 2000-08-14
US22526600P 2000-08-14 2000-08-14
US22544700P 2000-08-14 2000-08-14
US22527000P 2000-08-14 2000-08-14
US22451900P 2000-08-14 2000-08-14
US22521400P 2000-08-14 2000-08-14
US22451800P 2000-08-14 2000-08-14
US22575900P 2000-08-14 2000-08-14
US22526800P 2000-08-14 2000-08-14
US60/225,447 2000-08-14
US60/225,213 2000-08-14
US60/225,759 2000-08-14
US60/225,214 2000-08-14
US60/225,267 2000-08-14
US60/224,518 2000-08-14
US60/225,268 2000-08-14
US60/225,270 2000-08-14
US60/225,758 2000-08-14
US60/224,519 2000-08-14
US60/225,757 2000-08-14
US60/225,266 2000-08-14
US22627900P 2000-08-18 2000-08-18
US60/226,279 2000-08-18
US22668100P 2000-08-22 2000-08-22
US22686800P 2000-08-22 2000-08-22
US22718200P 2000-08-22 2000-08-22
US60/226,868 2000-08-22
US60/226,681 2000-08-22
US60/227,182 2000-08-22
US22700900P 2000-08-23 2000-08-23
US60/227,009 2000-08-23
US22892400P 2000-08-30 2000-08-30
US60/228,924 2000-08-30
US22934500P 2000-09-01 2000-09-01
US22928700P 2000-09-01 2000-09-01
US22934300P 2000-09-01 2000-09-01
US22934400P 2000-09-01 2000-09-01
US60/229,345 2000-09-01
US60/229,343 2000-09-01
US60/229,287 2000-09-01
US60/229,344 2000-09-01
US22951300P 2000-09-05 2000-09-05
US22950900P 2000-09-05 2000-09-05
US60/229,509 2000-09-05
US60/229,513 2000-09-05
US23043800P 2000-09-06 2000-09-06
US23043700P 2000-09-06 2000-09-06
US60/230,438 2000-09-06
US60/230,437 2000-09-06
US23124200P 2000-09-08 2000-09-08
US23141300P 2000-09-08 2000-09-08
US23124300P 2000-09-08 2000-09-08
US23208100P 2000-09-08 2000-09-08
US23124400P 2000-09-08 2000-09-08
US23208000P 2000-09-08 2000-09-08
US23141400P 2000-09-08 2000-09-08
US60/231,414 2000-09-08
US60/231,413 2000-09-08
US60/231,242 2000-09-08
US60/231,244 2000-09-08
US60/232,081 2000-09-08
US60/231,243 2000-09-08
US60/232,080 2000-09-08
US23196800P 2000-09-12 2000-09-12
US60/231,968 2000-09-12
US23306400P 2000-09-14 2000-09-14
US23306300P 2000-09-14 2000-09-14
US23306500P 2000-09-14 2000-09-14
US23240000P 2000-09-14 2000-09-14
US23239700P 2000-09-14 2000-09-14
US23239900P 2000-09-14 2000-09-14
US23239800P 2000-09-14 2000-09-14
US23240100P 2000-09-14 2000-09-14
US60/233,065 2000-09-14
US60/232,399 2000-09-14
US60/233,064 2000-09-14
US60/232,400 2000-09-14
US60/232,401 2000-09-14
US60/232,398 2000-09-14
US60/233,063 2000-09-14
US60/232,397 2000-09-14
US23422300P 2000-09-21 2000-09-21
US23427400P 2000-09-21 2000-09-21
US60/234,274 2000-09-21
US60/234,223 2000-09-21
US23499700P 2000-09-25 2000-09-25
US23499800P 2000-09-25 2000-09-25
US60/234,998 2000-09-25
US60/234,997 2000-09-25
US23548400P 2000-09-26 2000-09-26
US60/235,484 2000-09-26
US23583600P 2000-09-27 2000-09-27
US23583400P 2000-09-27 2000-09-27
US60/235,836 2000-09-27
US60/235,834 2000-09-27
US23636900P 2000-09-29 2000-09-29
US23632700P 2000-09-29 2000-09-29
US23636700P 2000-09-29 2000-09-29
US23637000P 2000-09-29 2000-09-29
US23636800P 2000-09-29 2000-09-29
US60/236,368 2000-09-29
US60/236,367 2000-09-29
US60/236,370 2000-09-29
US60/236,369 2000-09-29
US60/236,327 2000-09-29
US23704000P 2000-10-02 2000-10-02
US23703700P 2000-10-02 2000-10-02
US23703900P 2000-10-02 2000-10-02
US23680200P 2000-10-02 2000-10-02
US23703800P 2000-10-02 2000-10-02
US60/237,040 2000-10-02
US60/236,802 2000-10-02
US60/237,039 2000-10-02
US60/237,038 2000-10-02
US60/237,037 2000-10-02
US23993500P 2000-10-13 2000-10-13
US23993700P 2000-10-13 2000-10-13
US60/239,935 2000-10-13
US60/239,937 2000-10-13
US24182600P 2000-10-20 2000-10-20
US24180900P 2000-10-20 2000-10-20
US24178500P 2000-10-20 2000-10-20
US24122100P 2000-10-20 2000-10-20
US24096000P 2000-10-20 2000-10-20
US24180800P 2000-10-20 2000-10-20
US24178700P 2000-10-20 2000-10-20
US24178600P 2000-10-20 2000-10-20
US60/241,808 2000-10-20
US60/241,785 2000-10-20
US60/241,809 2000-10-20
US60/240,960 2000-10-20
US60/241,786 2000-10-20
US60/241,221 2000-10-20
US60/241,787 2000-10-20
US60/241,826 2000-10-20
US24461700P 2000-11-01 2000-11-01
US60/244,617 2000-11-01
US24647500P 2000-11-08 2000-11-08
US24652800P 2000-11-08 2000-11-08
US24647400P 2000-11-08 2000-11-08
US24661300P 2000-11-08 2000-11-08
US24661100P 2000-11-08 2000-11-08
US24661000P 2000-11-08 2000-11-08
US24660900P 2000-11-08 2000-11-08
US24653200P 2000-11-08 2000-11-08
US24652500P 2000-11-08 2000-11-08
US24647700P 2000-11-08 2000-11-08
US24652700P 2000-11-08 2000-11-08
US60/246,611 2000-11-08
US60/246,476 2000-11-08
US60/246,475 2000-11-08
US60/246,525 2000-11-08
US60/246,610 2000-11-08
US60/246,532 2000-11-08
US60/246,609 2000-11-08
US60/246,526 2000-11-08
US60/246,528 2000-11-08
US60/246,613 2000-11-08
US60/246,523 2000-11-08
US60/246,477 2000-11-08
US60/246,474 2000-11-08
US60/246,478 2000-11-08
US60/246,524 2000-11-08
US60/246,527 2000-11-08
US60/249,264 2000-11-17
US60/249,210 2000-11-17
US60/249,208 2000-11-17
US60/249,265 2000-11-17
US60/249,214 2000-11-17
US60/249,217 2000-11-17
US60/249,207 2000-11-17
US60/249,212 2000-11-17
US60/249,213 2000-11-17
US60/249,216 2000-11-17
US60/249,211 2000-11-17
US60/249,297 2000-11-17
US60/249,300 2000-11-17
US60/249,218 2000-11-17
US60/249,245 2000-11-17
US60/249,215 2000-11-17
US60/249,244 2000-11-17
US60/249,209 2000-11-17
US60/249,299 2000-11-17
US60/250,391 2000-12-01
US60/250,160 2000-12-01
US60/251,030 2000-12-05
US60/256,719 2000-12-05
US60/251,988 2000-12-05
US60/251,479 2000-12-06
US60/251,989 2000-12-08
US60/251,990 2000-12-08
US60/251,856 2000-12-08
US60/251,869 2000-12-08
US60/251,868 2000-12-08
US60/254,097 2000-12-11
US60/259,678 2001-01-05

Publications (2)

Publication Number Publication Date
WO2001055168A1 WO2001055168A1 (fr) 2001-08-02
WO2001055168A8 true WO2001055168A8 (fr) 2001-09-07

Family

ID=27587118

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2001/001331 Ceased WO2001055168A1 (fr) 2000-01-31 2001-01-17 Acides nucleiques, proteines, et anticorps
PCT/US2001/001320 Ceased WO2001055441A2 (fr) 2000-01-31 2001-01-17 Acides nucléiques, protéines et anticorps

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2001/001320 Ceased WO2001055441A2 (fr) 2000-01-31 2001-01-17 Acides nucléiques, protéines et anticorps

Country Status (2)

Country Link
CA (1) CA2395838A1 (fr)
WO (2) WO2001055168A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784746B2 (en) 1999-11-18 2006-06-08 Dendreon Corporation Nucleic acids encoding endotheliases, endotheliases and uses thereof
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2002006453A2 (fr) * 2000-07-18 2002-01-24 Bayer Aktiengesellschaft Regulation de protease a serine humaine de type desc1
CA2416732C (fr) 2000-08-02 2016-02-09 Brad St. Croix Profils d'expression de cellules endotheliales
WO2002072786A2 (fr) 2001-03-13 2002-09-19 Corvas International, Inc. Molecules d'acides nucleiques codant pour une serine protease transmembranaire 7, polypeptides codes et procedes associes
US7172892B2 (en) 2001-03-22 2007-02-06 Dendreon Corporation Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
WO2002077267A2 (fr) * 2001-03-27 2002-10-03 Dendreon San Diego Llc Molecules d'acide nucleique codant une serine protease transmembranaire 9, polypeptides codes et procedes fondes sur ces derniers
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7112430B2 (en) 2001-05-14 2006-09-26 Dendreon Corporation Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
WO2003012141A1 (fr) * 2001-07-31 2003-02-13 Takeda Chemical Industries, Ltd. Procede de recherche/criblage du gene associe a la maladie d'alzheimer
JPWO2003062429A1 (ja) * 2002-01-23 2005-05-26 山之内製薬株式会社 新規セリンプロテアーゼ

Also Published As

Publication number Publication date
WO2001055441A2 (fr) 2001-08-02
WO2001055168A1 (fr) 2001-08-02
CA2395838A1 (fr) 2001-08-02
WO2001055441A8 (fr) 2001-09-07

Similar Documents

Publication Publication Date Title
WO2001055309A8 (fr) Acides nucleiques, proteines et anticorps
WO2001090304A3 (fr) Acides nucleiques, proteines et anticorps
WO2001054472A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055306A8 (fr) Acides nucleiques, proteines, et anticorps
WO2001055326A3 (fr) Acides nucleiques, proteines et anticorps
WO2002026930A3 (fr) Acides nucleiques, proteines et anticorps
WO2001055168A8 (fr) Acides nucleiques, proteines, et anticorps
WO2001055440A8 (fr) Acides nucleiques, proteines et anticorps
WO2002072763A3 (fr) Acides nucleiques, proteines et anticorps
WO2001055167A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055162A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055449A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055305A3 (fr) Acides nucleiques, proteines, et anticorps

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED", ADD "WITH SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU."

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001910333

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001910333

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001910333

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase in:

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)